Robo Madness West→
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Founder and CEO of Brooks Bell Inc.
VP of Research & Policy, Ewing Marion Kauffman Foundation
Managing director, the Foundry Group
Founder, Gilt Groupe
Co-founder and partner at High Alpha
Chairman, CEO, & Founder, Alexandria Real Estate Equities
CEO and co-founder of BoostSuite
Cytokinetics (NASDAQ: CYTK) is a South San Francisco-based drug company developing treatments for neurological conditions such as amyotrophic lateral sclerosis (Lou Gehrig’s Disease).
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2016, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.